Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 30, 2023
- Accession no.
- 0001415889-23-001588
- Filed
- Jan 30, 2023
- Trade date
- Jan 26-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $113.08 | −$904,640 | 8,130 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −3,642 | $263.99F2 | −$961,451.58 | 4,488 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −4,292 | $264.38F3 | −$1,134,718.96 | 196 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −66 | $266.00 | −$17,556 | 130 | Direct | |
| Jan 27, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −2,380 | $258.93F4 | −$616,253.4 | 5,750 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −3,701 | $259.71F5 | −$961,186.71 | 2,049 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −794 | $260.68F6 | −$206,979.92 | 1,255 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −105 | $261.61F7 | −$27,469.05 | 1,150 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −1,020 | $262.94F8 | −$268,198.8 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 528,000 | Direct | |
| Jan 27, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 520,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $263.165 to $264.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $264.17 to $265.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $258.265 to $259.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $259.27 to $260.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
his transaction was executed in multiple trades at prices ranging from $260.27 to $261.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
his transaction was executed in multiple trades at prices ranging from $261.505 to $261.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
his transaction was executed in multiple trades at prices ranging from $262.61 to $263.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.